Clinique de Flandre
- Address
- lock Available on a paid plan
Clinique de Flandre - Precision Oncology in Breast Cancer
Clinique de Flandre is a specialized clinical research center focused on advancing precision medicine approaches in oncology, particularly in the treatment of metastatic breast cancer. The center demonstrates expertise in utilizing cutting-edge biomarker-driven therapy selection, incorporating circulating tumor DNA (ctDNA) analysis to guide treatment decisions for patients with hormone receptor-positive, HER2-negative breast cancers.
- Metastatic breast cancer research with focus on HR+/HER2- subtypes
- Precision medicine using liquid biopsy and ctDNA detection
- Targeted therapy trials combining PI3K and CDK4/6 inhibitors
The center's research portfolio emphasizes personalized treatment strategies, particularly investigating the role of PIK3CA mutations in treatment selection. Their innovative approach includes monitoring molecular alterations during therapy to optimize subsequent treatment lines, evaluating combinations of alpelisib and ribociclib with hormonal agents for improved patient outcomes in advanced breast cancer settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique de Flandre
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Circulating Tumor DNA-Guided Adjuvant Therapy with Fluorouracil, Folinic Acid, and Oxaliplatin in Stage II Colon Carcinoma | Centre Hospitalier Universitaire De Dijon | Phase III | Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 4 | Unknown | 2023-06-23 | 2026-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.